Teva's Links to Opioid Epidemic May Triple Funding Costs - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Teva closes in on Allergan's generics unit
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
U.S. charges Teva in generic drugs price-fixing probe
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva considers sale of its active ingredients unit: Bloomberg - YouTube
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Teva Seeking to Break Its Streak of Post-Earnings Stock Losses - Bloomberg
Teva (TEVA), AbbVie (ABBV) to Pay $161.5 Million in West Virginia Opioid Case - Bloomberg
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
Teva's job-cut tally could touch 10K: report | Fierce Pharma
Meet the Women of Bloomberg TV
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva (TEVA) Explores Sale of $2 Billion Active Ingredients Unit - Bloomberg
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
